|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q83495008
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010741.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q83495008
|
|
024
|
|
|
‡a
0000-0002-4772-9339
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q83495008
|
|
100
|
0 |
|
‡a
Patrícia M R Pereira
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Patrícia M R Pereira
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy
|
|
670
|
|
|
‡a
Author's Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications.
|
|
670
|
|
|
‡a
Author's Antibody-Targeted Imaging of Gastric Cancer
|
|
670
|
|
|
‡a
Author's Aromatic carbohydrate amphiphile disrupts cancer spheroids and prevents relapse
|
|
670
|
|
|
‡a
Author's Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.
|
|
670
|
|
|
‡a
Author's Carbon-1 versus carbon-3 linkage of D-galactose to porphyrins: Synthesis, uptake, and photodynamic efficiency.
|
|
670
|
|
|
‡a
Author's Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
|
|
670
|
|
|
‡a
Author's Dual functionality of phosphonic-acid-appended phthalocyanines: inhibitors of urokinase plasminogen activator and anticancer photodynamic agents.
|
|
670
|
|
|
‡a
Author's Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy.
|
|
670
|
|
|
‡a
Author's Galactodendritic porphyrinic conjugates as new biomimetic catalysts for oxidation reactions.
|
|
670
|
|
|
‡a
Author's HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer
|
|
670
|
|
|
‡a
Author's Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond.
|
|
670
|
|
|
‡a
Author's Imidazole and imidazolium porphyrins: gas-phase chemistry of multicharged ions.
|
|
670
|
|
|
‡a
Author's Mitochondria-Targeted Photodynamic Therapy with a Galactodendritic Chlorin to Enhance Cell Death in Resistant Bladder Cancer Cells
|
|
670
|
|
|
‡a
Author's Multicharged Phthalocyanines as Selective Ligands for G-Quadruplex DNA Structures
|
|
670
|
|
|
‡a
Author's New platinum(II)-bipyridyl corrole complexes: Synthesis, characterization and binding studies with DNA and HSA.
|
|
670
|
|
|
‡a
Author's Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy
|
|
670
|
|
|
‡a
Author's Porphyrin and phthalocyanine glycodendritic conjugates: synthesis, photophysical and photochemical properties
|
|
670
|
|
|
‡a
Author's Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in targeted destruction of human bladder cancer cells.
|
|
670
|
|
|
‡a
Author's Synthesis, characterization and biomolecule-binding properties of novel tetra-platinum(ii)-thiopyridylporphyrins
|
|
670
|
|
|
‡a
Author's Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
|
|
670
|
|
|
‡a
Author's The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes
|
|
670
|
|
|
‡a
Author's The role of galectin-1 in in vitro and in vivo photodynamic therapy with a galactodendritic porphyrin.
|
|
909
|
|
|
‡a
(orcid) 0000000247729339
‡9
1
|
|
919
|
|
|
‡a
cancercellspheroidsareabetterscreenforthephotodynamicefficiencyofglycosylatedphotosensitizers
‡A
Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.
‡9
1
|
|
919
|
|
|
‡a
caveolin1mediatescellulardistributionofher2andaffectstrastuzumabbindingandtherapeuticefficacy
‡A
Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
‡9
1
|
|
919
|
|
|
‡a
dualfunctionalityofphosphonicacidappendedphthalocyaninesinhibitorsofurokinaseplasminogenactivatorandanticancerphotodynamicagents
‡A
Dual functionality of phosphonic-acid-appended phthalocyanines: inhibitors of urokinase plasminogen activator and anticancer photodynamic agents.
‡9
1
|
|
919
|
|
|
‡a
galactodendriticphthalocyaninetargetscarbohydratebindingproteinsenhancingphotodynamictherapy
‡A
Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy.
‡9
1
|
|
919
|
|
|
‡a
galactodendriticporphyrinicconjugatesasnewbiomimeticcatalystsforoxidationreactions
‡A
Galactodendritic porphyrinic conjugates as new biomimetic catalysts for oxidation reactions.
‡9
1
|
|
919
|
|
|
‡a
her2targetedpetimagingandtherapyofhyaluronanmaskedher2overexpressingbreastcancer
‡A
HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer
‡9
1
|
|
919
|
|
|
‡a
imagingofhumanepidermalgrowthfactorreceptorsforpatientselectionandresponsemonitoringfrompetimagingandbeyond
‡A
Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond.
‡9
1
|
|
919
|
|
|
‡a
imidazoleandimidazoliumporphyrinsgasphasechemistryofmultichargedions
‡A
Imidazole and imidazolium porphyrins: gas-phase chemistry of multicharged ions.
‡9
1
|
|
919
|
|
|
‡a
mitochondriatargetedphotodynamictherapywithagalactodendriticchlorintoenhancecelldeathinresistantbladdercancercells
‡A
Mitochondria-Targeted Photodynamic Therapy with a Galactodendritic Chlorin to Enhance Cell Death in Resistant Bladder Cancer Cells
‡9
1
|
|
919
|
|
|
‡a
multichargedphthalocyaninesasselectiveligandsforgquadruplexdnastructures
‡A
Multicharged Phthalocyanines as Selective Ligands for G-Quadruplex DNA Structures
‡9
1
|
|
919
|
|
|
‡a
newplatinum2bipyridylcorrolecomplexessynthesischaracterizationandbindingstudieswithdnaandhsa
‡A
New platinum(II)-bipyridyl corrole complexes: Synthesis, characterization and binding studies with DNA and HSA.
‡9
1
|
|
919
|
|
|
‡a
photoimmunoconjugatesnovelsyntheticstrategiestotargetandtreatcancerbyphotodynamictherapy
‡A
Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy
‡9
1
|
|
919
|
|
|
‡a
porphyrinandphthalocyanineglycodendriticconjugatessynthesisphotophysicalandphotochemicalproperties
‡A
Porphyrin and phthalocyanine glycodendritic conjugates: synthesis, photophysical and photochemical properties
‡9
1
|
|
919
|
|
|
‡a
porphyrinconjugatedwithserumalbuminsandmonoclonalantibodiesboostsefficiencyintargeteddestructionofhumanbladdercancercells
‡A
Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in targeted destruction of human bladder cancer cells.
‡9
1
|
|
919
|
|
|
‡a
synthesischaracterizationandbiomoleculebindingpropertiesofnoveltetraplatinum2thiopyridylporphyrins
‡A
Synthesis, characterization and biomolecule-binding properties of novel tetra-platinum(ii)-thiopyridylporphyrins
‡9
1
|
|
919
|
|
|
‡a
temporalmodulationofher2membraneavailabilityincreasespertuzumabuptakeandpretargetedmolecularimagingofgastrictumors
‡A
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
‡9
1
|
|
919
|
|
|
‡a
dipeptidylpeptidase4inhibitorsitagliptinimprovesoxidativestressandamelioratesglomerularlesionsinaratmodeloftype1diabetes
‡A
The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes
‡9
1
|
|
919
|
|
|
‡a
roleofgalectin1ininvitroandinvivophotodynamictherapywithagalactodendriticporphyrin
‡A
The role of galectin-1 in in vitro and in vivo photodynamic therapy with a galactodendritic porphyrin.
‡9
1
|
|
919
|
|
|
‡a
carbon1versuscarbon3linkageof500galactosetoporphyrinssynthesisuptakeandphotodynamicefficiency
‡A
Carbon-1 versus carbon-3 linkage of D-galactose to porphyrins: Synthesis, uptake, and photodynamic efficiency.
‡9
1
|
|
919
|
|
|
‡a
amphiphilicphthalocyaninecyclodextrinconjugatesforcancerphotodynamictherapy
‡A
Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy
‡9
1
|
|
919
|
|
|
‡a
antibodiesarmedwithphotosensitizersfromchemicalsynthesistophotobiologicalapplications
‡A
Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications.
‡9
1
|
|
919
|
|
|
‡a
antibodytargetedimagingofgastriccancer
‡A
Antibody-Targeted Imaging of Gastric Cancer
‡9
1
|
|
919
|
|
|
‡a
aromaticcarbohydrateamphiphiledisruptscancerspheroidsandpreventsrelapse
‡A
Aromatic carbohydrate amphiphile disrupts cancer spheroids and prevents relapse
‡9
1
|
|
996
|
|
|
‡2
DNB|1145675352
|
|
996
|
|
|
‡2
PTBNP|959002
|
|
996
|
|
|
‡2
PTBNP|1656202
|
|
996
|
|
|
‡2
ISNI|000000039084687X
|
|
996
|
|
|
‡2
PTBNP|1333267
|
|
996
|
|
|
‡2
PTBNP|1671651
|
|
996
|
|
|
‡2
PTBNP|1629078
|
|
996
|
|
|
‡2
ISNI|0000000070313775
|
|
996
|
|
|
‡2
ISNI|0000000389544321
|
|
996
|
|
|
‡2
BLBNB|001543614
|
|
996
|
|
|
‡2
NTA|128950358
|
|
996
|
|
|
‡2
PTBNP|1437155
|
|
996
|
|
|
‡2
DNB|1218809256
|
|
996
|
|
|
‡2
PTBNP|1689767
|
|
996
|
|
|
‡2
LC|no2023120082
|
|
996
|
|
|
‡2
PTBNP|1378270
|
|
996
|
|
|
‡2
SUDOC|232342954
|
|
996
|
|
|
‡2
J9U|987007359553305171
|
|
996
|
|
|
‡2
SUDOC|198689306
|
|
996
|
|
|
‡2
BIBSYS|90526208
|
|
996
|
|
|
‡2
LC|n 2024254979
|
|
996
|
|
|
‡2
DNB|1296641902
|
|
996
|
|
|
‡2
LC|no2018010367
|
|
996
|
|
|
‡2
PLWABN|9811461526605606
|
|
996
|
|
|
‡2
PLWABN|9812405947705606
|
|
996
|
|
|
‡2
PTBNP|1461101
|
|
996
|
|
|
‡2
ISNI|0000000069931525
|
|
996
|
|
|
‡2
SUDOC|249826712
|
|
996
|
|
|
‡2
BLBNB|000552924
|
|
996
|
|
|
‡2
SUDOC|246843403
|
|
996
|
|
|
‡2
PTBNP|1012073
|
|
996
|
|
|
‡2
BLBNB|001575935
|
|
996
|
|
|
‡2
ISNI|000000003181274X
|
|
996
|
|
|
‡2
PTBNP|1386522
|
|
996
|
|
|
‡2
ISNI|0000000068083181
|
|
996
|
|
|
‡2
PTBNP|1381842
|
|
996
|
|
|
‡2
BLBNB|000271849
|
|
996
|
|
|
‡2
DNB|1217502335
|
|
996
|
|
|
‡2
ISNI|000000007021278X
|
|
996
|
|
|
‡2
BLBNB|001487377
|
|
996
|
|
|
‡2
PTBNP|1472754
|
|
996
|
|
|
‡2
LC|n 88601475
|
|
996
|
|
|
‡2
SUDOC|223456918
|
|
996
|
|
|
‡2
ISNI|0000000070537859
|
|
996
|
|
|
‡2
LC|n 2018046375
|
|
996
|
|
|
‡2
PTBNP|1872028
|
|
996
|
|
|
‡2
ISNI|0000000391978313
|
|
996
|
|
|
‡2
LC|no2016114070
|
|
996
|
|
|
‡2
ISNI|0000000358140658
|
|
996
|
|
|
‡2
PTBNP|938663
|
|
996
|
|
|
‡2
PTBNP|1251518
|
|
996
|
|
|
‡2
PTBNP|1679979
|
|
996
|
|
|
‡2
DNB|1199954365
|
|
996
|
|
|
‡2
RERO|A003681730
|
|
996
|
|
|
‡2
LC|n 2014203838
|
|
996
|
|
|
‡2
ISNI|0000000069482758
|
|
996
|
|
|
‡2
BLBNB|000539042
|
|
996
|
|
|
‡2
ISNI|0000000082850201
|
|
996
|
|
|
‡2
ISNI|0000000428245755
|
|
996
|
|
|
‡2
ISNI|0000000431720422
|
|
996
|
|
|
‡2
ISNI|0000000068093021
|
|
996
|
|
|
‡2
LC|n 96067413
|
|
996
|
|
|
‡2
SUDOC|09511291X
|
|
996
|
|
|
‡2
PTBNP|910935
|
|
996
|
|
|
‡2
LC|n 2015238058
|
|
996
|
|
|
‡2
NTA|362927545
|
|
996
|
|
|
‡2
PTBNP|1384153
|
|
996
|
|
|
‡2
BLBNB|000537962
|
|
996
|
|
|
‡2
PTBNP|1807530
|
|
996
|
|
|
‡2
BNF|15002602
|
|
996
|
|
|
‡2
ISNI|0000000069302219
|
|
996
|
|
|
‡2
PTBNP|1692247
|
|
996
|
|
|
‡2
BLBNB|000392374
|
|
996
|
|
|
‡2
PTBNP|1245395
|
|
996
|
|
|
‡2
PTBNP|1609331
|
|
996
|
|
|
‡2
PTBNP|1536021
|
|
996
|
|
|
‡2
PTBNP|147740
|
|
996
|
|
|
‡2
LC|n 2010041704
|
|
996
|
|
|
‡2
ISNI|0000000070306006
|
|
996
|
|
|
‡2
LC|n 2011214013
|
|
996
|
|
|
‡2
ISNI|0000000454195288
|
|
996
|
|
|
‡2
NSK|000538313
|
|
996
|
|
|
‡2
BNF|17940340
|
|
996
|
|
|
‡2
SUDOC|18516546X
|
|
996
|
|
|
‡2
LC|no2023028259
|
|
996
|
|
|
‡2
ISNI|0000000358625997
|
|
996
|
|
|
‡2
NUKAT|nx2024285478
|
|
996
|
|
|
‡2
PTBNP|1238423
|
|
996
|
|
|
‡2
DNB|1213674271
|
|
996
|
|
|
‡2
RERO|A012345950
|
|
996
|
|
|
‡2
PTBNP|1862892
|
|
996
|
|
|
‡2
ISNI|0000000069225575
|
|
996
|
|
|
‡2
SUDOC|125496389
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
